AstraZeneca Canada Inc. et al. v Sandoz Canada Inc.

Call to arrange a consultation

2020

T-28-20

Pending

New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent No. 2,402,894 (saxagliptin)

Counsel to:

Sandoz Canada Inc.

The decision is reported

Partner

Associate